Few corporate controversies in India have generated as much debate as the long-running Sterling Biotech matter and the legal proceedings involving members of the Sandesara family. For years, the case occupied a central place in discussions surrounding alleged bank frauds, financial misconduct, regulatory failures, corporate accountability, and the ability of influential business groups to navigate ...